Optimized workflow for pulmonary vein isolation using 90-W radiofrequency applications: a comparative study.
Ablation index
Combined strategy
Paroxysmal atrial fibrillation
Pulmonary vein isolation
Radiofrequency
Very high-power short-duration
Journal
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966
Informations de publication
Date de publication:
28 Aug 2023
28 Aug 2023
Historique:
received:
28
06
2023
accepted:
22
08
2023
medline:
28
8
2023
pubmed:
28
8
2023
entrez:
28
8
2023
Statut:
aheadofprint
Résumé
Ninety-watt applications are more sensitive to catheter instability and produce lesions that are shallower and smaller in diameter than 50-W applications. These characteristics were considered for the development of a combined (90-50 W) pulmonary vein isolation (PVI) strategy which was prospectively compared to a 50 W-only ablation index (AI)-guided PVI strategy. One hundred fifty consecutive paroxysmal AF patients underwent PVI under general anesthesia using CARTO. In the first 75 patients, PVI was performed with a combined (90-50 W) strategy using the QDOT-MICRO catheter in a temperature-controlled mode. This strategy consisted of 90 W-4 s applications on the posterior LA wall (at sites of catheter stability and expectedly thin atrial tissue) with an interlesion distance (ILD) ≤ 4 mm and 50-W applications elsewhere (at sites of catheter instability or expectedly thick atrial tissue) with ILD < 6 mm. In the subsequent 75 patients, PVI was performed with a 50 W-only AI-guided strategy using the SmartTouch-SF catheter in a power-controlled mode. Both groups of patients had similar clinical characteristics and LA dimensions (123.1 ± 24.9 ml vs 119 ± 26.8 ml, P = 0.33). Total procedural times (61 [56-70] vs 65 [60-75] min, P = 0.12), first-pass PVI (82.6 vs 80%, P = 0.81), acute PV reconnection (0 vs 6.6%, P = 0.05), and 1-year SR maintenance (93.3 vs 90.6%, P = 0.57) rates were also similar in both groups of patients. There were no complications in the combined (90-50 W) group while only 2 groin hematomas were reported in the 50 W group. In paroxysmal AF patients, a combined (90-50 W) strategy for PVI did not improve safety, efficiency, or effectiveness compared to a 50 W-only AI-guided strategy.
Sections du résumé
BACKGROUND
BACKGROUND
Ninety-watt applications are more sensitive to catheter instability and produce lesions that are shallower and smaller in diameter than 50-W applications. These characteristics were considered for the development of a combined (90-50 W) pulmonary vein isolation (PVI) strategy which was prospectively compared to a 50 W-only ablation index (AI)-guided PVI strategy.
METHODS
METHODS
One hundred fifty consecutive paroxysmal AF patients underwent PVI under general anesthesia using CARTO. In the first 75 patients, PVI was performed with a combined (90-50 W) strategy using the QDOT-MICRO catheter in a temperature-controlled mode. This strategy consisted of 90 W-4 s applications on the posterior LA wall (at sites of catheter stability and expectedly thin atrial tissue) with an interlesion distance (ILD) ≤ 4 mm and 50-W applications elsewhere (at sites of catheter instability or expectedly thick atrial tissue) with ILD < 6 mm. In the subsequent 75 patients, PVI was performed with a 50 W-only AI-guided strategy using the SmartTouch-SF catheter in a power-controlled mode.
RESULTS
RESULTS
Both groups of patients had similar clinical characteristics and LA dimensions (123.1 ± 24.9 ml vs 119 ± 26.8 ml, P = 0.33). Total procedural times (61 [56-70] vs 65 [60-75] min, P = 0.12), first-pass PVI (82.6 vs 80%, P = 0.81), acute PV reconnection (0 vs 6.6%, P = 0.05), and 1-year SR maintenance (93.3 vs 90.6%, P = 0.57) rates were also similar in both groups of patients. There were no complications in the combined (90-50 W) group while only 2 groin hematomas were reported in the 50 W group.
CONCLUSIONS
CONCLUSIONS
In paroxysmal AF patients, a combined (90-50 W) strategy for PVI did not improve safety, efficiency, or effectiveness compared to a 50 W-only AI-guided strategy.
Identifiants
pubmed: 37639157
doi: 10.1007/s10840-023-01630-9
pii: 10.1007/s10840-023-01630-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Nakagawa H, Ikeda A, Sharma T, et al. Comparison of in vivo tissue temperature profile and lesion geometry for radiofrequency ablation with high power-short duration and moderate power-moderate duration: effects of thermal latency and contact force on lesion formation. Circ Arrhythm Electrophysiol. 2021;14:e009899.
doi: 10.1161/CIRCEP.121.009899
pubmed: 34138641
Bortone A, Albenque JP, Ramirez FD, et al. 90 vs 50-watt radiofrequency applications for pulmonary vein isolation: experimental and clinical findings. Circ Arrhythm Electrophysiol. 2022;15:e010663.
doi: 10.1161/CIRCEP.121.010663
pubmed: 35363039
Duytschaever M, Vijgen J, De Potter T, et al. Standardized pulmonary vein isolation workflow to enclose veins with contiguous lesions: the multicentre VISTAX trial. Europace. 2020;22:1645–52.
doi: 10.1093/europace/euaa157
pubmed: 32879974
Suenari K, Nakano H, Hirai Y, et al. Left atrial thickness under the catheter ablation lines in patients with paroxysmal atrial fibrillation: insights from 64-slice multidetector computed tomography. Heart Vessels. 2013;28:360–8.
doi: 10.1007/s00380-012-0253-6
pubmed: 22526381
O’Neill L, El Haddad M, Berte B, et al. Very high-power ablation for contiguous pulmonary vein isolation. Results from the randomized POWER PLUS trial. JACC Clin Electrophysiol. 2023;9:511–22.
doi: 10.1016/j.jacep.2022.10.039
pubmed: 36752467
Bourier F, Duchateau J, Vlachos K, et al. High-power short-duration versus standard radiofrequency ablation: insights on lesion metrics. J Cardiovasc Electrophysiol. 2018;29(11):1570–5.
doi: 10.1111/jce.13724
pubmed: 30168230
Sun X, Niu G, Lin J, et al. The incidence and location of epicardial connections in the era of contact force guided ablation for pulmonary vein isolation. J Cardiovasc Electrophysiol. 2021;32:2381–90.
doi: 10.1111/jce.15174
pubmed: 34270147
Mueller J, Nentwich K, Ene E, et al. Radiofrequency ablation for atrial fibrillation-50W or 90W? J Cardiovasc Electrophysiol. 2022. https://doi.org/10.1111/jce.15681 .
doi: 10.1111/jce.15681
pubmed: 36321661
Leshem E, Zilberman I, Tschabrunn CM, Barkagan M, Contreras-Valdes FM, Govbari A, Anter E. High-power and short-duration ablation for pulmonary vein isolation: biophysical characterization. JACC Clin Electrophysiol. 2018;4(4):467–79.
doi: 10.1016/j.jacep.2017.11.018
pubmed: 30067486
Sultan A, Lüker J, Hoffmann B, et al. Interventional management of recurrent paroxysmal atrial fibrillation despite isolated pulmonary veins: impact of an ablation strategy targeting inducible atrial tachyarrhythmias. Europace. 2016;18:994–9.
doi: 10.1093/europace/euv332
pubmed: 26462703
Sadek MM, Maeda S, Chik W, et al. Recurrent atrial arrhythmias in the setting of chronic pulmonary vein isolation. Heart Rhythm. 2016;13:2174–80.
doi: 10.1016/j.hrthm.2016.08.026
pubmed: 27544746
Hoffmann P, Diaz Ramirez I, Baldenhofer G, Stangl K, Mont L, Althoff TF. Randomized study defining the optimum target interlesion distance in ablation index-guided atrial fibrillation ablation. Europace. 2020;22:1480–6.
doi: 10.1093/europace/euaa147
pubmed: 32729896